Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPCORITAMAB-BYSP vs EPIRUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPCORITAMAB-BYSP vs EPIRUBICIN: Safety Overview

Metric EPCORITAMAB-BYSP EPIRUBICIN
Total FAERS Reports 978 16,274
Deaths Reported 341 2,212
Death Rate 34.9% 13.6%
Hospitalizations 199 5,603
Average Patient Age 71.6 yrs 52.8 yrs
% Female Patients 41.6% 86.1%
FDA Approval Date N/A Apr 15, 2011
Manufacturer N/A Pharmacia & Upjohn Company LLC
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription